Company intelligence / Profile preview

HabitNu

Chicago, Illinois, United States

Ownership: Private
Development stage: Other

Overview

HabitNu offers evidence-based digital programs for weight loss, diabetes prevention, and chronic care management, leveraging telehealth and behavior tracking. It is recognized by the CDC for its Diabetes Prevention Program.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Non-pharmacological therapyBehavioral modification
Industry: Digital Health Medical Devices

Partnerships

Centers for Disease Control and Prevention (CDC)Centers for Medicare & Medicaid Services (CMS)

Beyond the preview

Go deeper on HabitNu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HabitNu.

Explore the full profile